Countdown to UnitedHealth (UNH) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

22.01.26 15:15 Uhr

Werte in diesem Artikel
Aktien

300,75 EUR 5,75 EUR 1,95%

Indizes

PKT PKT

49.537,1 PKT 459,8 PKT 0,94%

18.653,4 PKT 173,6 PKT 0,94%

3.417,5 PKT 30,0 PKT 0,89%

6.925,0 PKT 49,4 PKT 0,72%

Wall Street analysts expect UnitedHealth Group (UNH) to post quarterly earnings of $2.09 per share in its upcoming report, which indicates a year-over-year decline of 69.3%. Revenues are expected to be $113.26 billion, up 12.4% from the year-ago quarter.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.That said, let's delve into the average estimates of some UnitedHealth metrics that Wall Street analysts commonly model and monitor.Analysts' assessment points toward 'Revenues- Investment and other income' reaching $1.11 billion. The estimate suggests a change of -28.2% year over year.Analysts forecast 'Revenues- Services' to reach $9.47 billion. The estimate indicates a change of +1.8% from the prior-year quarter.According to the collective judgment of analysts, 'Revenues- UnitedHealthcare- Employer & Individual- Global' should come in at $829.74 million. The estimate suggests a change of +7.1% year over year.The consensus estimate for 'Revenues- Products' stands at $13.86 billion. The estimate indicates a year-over-year change of +2.9%.Analysts predict that the 'UnitedHealthcare Customer Profile - People Served - Total Commercial - Domestic' will reach 30.02 million. The estimate is in contrast to the year-ago figure of 29.73 million.The consensus among analysts is that 'UnitedHealthcare Customer Profile - People Served - Commercial - Domestic - Risk-based' will reach 8.45 million. The estimate compares to the year-ago value of 8.85 million.The combined assessment of analysts suggests that 'UnitedHealthcare Customer Profile - People Served - Commercial - Domestic - Fee-based' will likely reach 21.57 million. Compared to the current estimate, the company reported 20.89 million in the same quarter of the previous year.The collective assessment of analysts points to an estimated 'UnitedHealthcare Customer Profile - People Served - Total Community and Senior' of 20.36 million. The estimate is in contrast to the year-ago figure of 19.62 million.It is projected by analysts that the 'UnitedHealthcare Customer Profile - People Served - Community and Senior - Medicare Advantage' will reach 8.50 million. Compared to the current estimate, the company reported 7.85 million in the same quarter of the previous year.The average prediction of analysts places 'UnitedHealthcare Customer Profile - People Served - Community and Senior - Medicare Supplement (Standardized)' at 4.29 million. The estimate is in contrast to the year-ago figure of 4.34 million.Based on the collective assessment of analysts, 'UnitedHealthcare Customer Profile - People Served - Medicare Part D stand-alone' should arrive at 2.76 million. Compared to the current estimate, the company reported 3.05 million in the same quarter of the previous year.Analysts expect 'UnitedHealthcare Customer Profile - People Served - Total UnitedHealthcare - Medical' to come in at 50.38 million. Compared to the present estimate, the company reported 50.68 million in the same quarter last year. View all Key Company Metrics for UnitedHealth here>>> UnitedHealth shares have witnessed a change of +6.2% in the past month, in contrast to the Zacks S&P 500 composite's +0.7% move. With a Zacks Rank #3 (Hold), UNH is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: UnitedHealth und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Q4

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q4

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu UnitedHealth Inc.

Wer­bung

Analysen zu UnitedHealth Inc.

DatumRatingAnalyst
14.04.2022UnitedHealth OutperformRBC Capital Markets
15.10.2020UnitedHealth OutperformCredit Suisse Group
14.10.2020UnitedHealth OutperformRBC Capital Markets
29.08.2019UnitedHealth OutperformCredit Suisse Group
17.07.2018UnitedHealth buyGoldman Sachs Group Inc.
DatumRatingAnalyst
14.04.2022UnitedHealth OutperformRBC Capital Markets
15.10.2020UnitedHealth OutperformCredit Suisse Group
14.10.2020UnitedHealth OutperformRBC Capital Markets
29.08.2019UnitedHealth OutperformCredit Suisse Group
17.07.2018UnitedHealth buyGoldman Sachs Group Inc.
DatumRatingAnalyst
09.11.2016UnitedHealth Group NeutralMizuho
31.03.2011UnitedHealth Group performOppenheimer & Co. Inc.
08.02.2011UnitedHealth Group neutralGoldman Sachs Group Inc.
15.11.2010UnitedHealth Group holdStifel, Nicolaus & Co., Inc.
20.04.2010UnitedHealth neutralWedbush Morgan Securities Inc.
DatumRatingAnalyst
11.06.2009UnitedHealth underperformOppenheimer & Co. Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für UnitedHealth Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen